Recent clinical trials with new antihyperglycemic agents demonstrate cardiovascular safety and improved outcomes, emphasizing the importance of these newer medications on improving cardiovascular health outcomes (Table 2).
Noting that social determinants of health account for 80-90% of health outcomes,2 authors call for both direct and upstream solutions to manage cardiovascular risk factors in patients with T2D.
- Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722-e759. doi:10.1161/CIR.0000000000001040.
- Havranek EP, Mujahid MS, Barr DA, et al; on behalf of the American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–898. 10.1161/CIR.0000000000000228.